Related Experiment Video
Updated: Jan 6, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
A multimodal framework for comprehensive driver variant prediction in cancer
Hai Yang1,2, Yijia Chen2, Tianyi Zhou3
1Key Laboratory of Smart Manufacturing in Energy Chemical Process Ministry of Education, East China University of Science and Technology, Shanghai, China.
Background:
Cancer genomes contain many mutations, but only a subset drive tumor development. Accurately pinpointing these driver variants remains challenging. We aim to build an accurate and interpretable model by combining DNA sequence, protein 3D structure, and cancer omics data.
Methods:
We present ModVAR, a multimodal model that integrates DNA sequences, predicted protein tertiary structures, and cancer omics data to classify driver variants. The approach uses pre-trained models (DNAbert2 and ESMFold) and a self-supervised strategy for cancer omics profiles. We evaluate performance on clinically and experimentally validated driver variants with standard classification metrics, examine therapeutic relevance through molecular docking, assess modeling of variants in intrinsically disordered protein regions, and analyze modality contributions.
Results:
Here we show that ModVAR achieves strong accuracy across benchmarks for identifying validated driver variants. It prioritizes variants with potential therapeutic actionability supported by docking analyses, and the inclusion of structural predictions enables effective modeling of variants in intrinsically disordered regions. Interpretation indicates that the protein structure modality contributes most to predictions. At scale, the method produces 3,971,946 publicly available variant annotations.
Conclusions:
ModVAR integrates sequence, structure, and cancer omics signals to aid driver-variant discovery. It provides robust performance across tasks, supports hypothesis generation and target discovery, and supplies a large-scale resource that advances cancer research and personalized therapy.
Related Concept Videos
Cancer Survival Analysis
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell

